These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 14693778)
1. The relation of Graves' ophthalmopathy to circulating thyroid hormone status. Kim JM; LaBree L; Levin L; Feldon SE Br J Ophthalmol; 2004 Jan; 88(1):72-4. PubMed ID: 14693778 [TBL] [Abstract][Full Text] [Related]
2. Effect of abnormal thyroid function on the severity of Graves' ophthalmopathy. Prummel MF; Wiersinga WM; Mourits MP; Koornneef L; Berghout A; van der Gaag R Arch Intern Med; 1990 May; 150(5):1098-101. PubMed ID: 1691908 [TBL] [Abstract][Full Text] [Related]
3. The relationship between quality of life, cognition, and thyroid status in Graves' disease. Riguetto CM; Neto AM; Tambascia MA; Zantut-Wittmann DE Endocrine; 2019 Jan; 63(1):87-93. PubMed ID: 30173328 [TBL] [Abstract][Full Text] [Related]
4. Clinical Implications of Immunoglobulin G4 to Graves' Ophthalmopathy. Yu SH; Kang JG; Kim CS; Ihm SH; Choi MG; Yoo HJ; Lee SJ Thyroid; 2017 Sep; 27(9):1185-1193. PubMed ID: 28805160 [TBL] [Abstract][Full Text] [Related]
5. Plasma leptin concentrations in patients with Graves' disease with or without ophthalmopathy. Ozata M; Uckaya G; Bolu E; Corapcioglu D; Bingol N; Ozdemir IC Med Sci Monit; 2001; 7(4):696-700. PubMed ID: 11433197 [TBL] [Abstract][Full Text] [Related]
6. The balance shift in Th1/Th2 related IL-12/IL-5 cytokines in Graves' disease during methimazole therapy. Molnár I Autoimmunity; 2007 Feb; 40(1):31-7. PubMed ID: 17364495 [TBL] [Abstract][Full Text] [Related]
7. Serum IL-18 levels are not increased in patients with untreated Graves' ophthalmopathy. Wakelkamp IM; Prummel MF; Wiersinga WM Horm Metab Res; 2004 Jan; 36(1):44-7. PubMed ID: 14983406 [TBL] [Abstract][Full Text] [Related]
8. TSHR intronic polymorphisms (rs179247 and rs12885526) and their role in the susceptibility of the Brazilian population to Graves' disease and Graves' ophthalmopathy. Bufalo NE; Dos Santos RB; Marcello MA; Piai RP; Secolin R; Romaldini JH; Ward LS J Endocrinol Invest; 2015 May; 38(5):555-61. PubMed ID: 25543543 [TBL] [Abstract][Full Text] [Related]
9. Temporal relationship between onset of Graves' ophthalmopathy and onset of thyroidal Graves' disease. Wiersinga WM; Smit T; van der Gaag R; Koornneef L J Endocrinol Invest; 1988 Sep; 11(8):615-9. PubMed ID: 2907524 [TBL] [Abstract][Full Text] [Related]
10. Comparative study on IgG and IgA antibodies against human thyroid and eye-muscle antigens in Graves' ophthalmopathy. Molnár I; Balázs C Acta Med Hung; 1991; 48(1-2):13-21. PubMed ID: 1813853 [TBL] [Abstract][Full Text] [Related]
11. Graves' dermopathy and acropachy are markers of severe Graves' ophthalmopathy. Fatourechi V; Bartley GB; Eghbali-Fatourechi GZ; Powell CC; Ahmed DD; Garrity JA Thyroid; 2003 Dec; 13(12):1141-4. PubMed ID: 14751035 [TBL] [Abstract][Full Text] [Related]
12. Limited genetic susceptibility to severe Graves' ophthalmopathy: no role for CTLA-4 but evidence for an environmental etiology. Villanueva R; Inzerillo AM; Tomer Y; Barbesino G; Meltzer M; Concepcion ES; Greenberg DA; MacLaren N; Sun ZS; Zhang DM; Tucci S; Davies TF Thyroid; 2000 Sep; 10(9):791-8. PubMed ID: 11041456 [TBL] [Abstract][Full Text] [Related]
19. Soluble intercellular adhesion molecule-1 (sICAM-1) in Graves' disease. Balázs C; Kiss E Acta Microbiol Immunol Hung; 1994; 41(4):451-6. PubMed ID: 7866729 [TBL] [Abstract][Full Text] [Related]
20. Cloning and characterization of the novel thyroid and eye muscle shared protein G2s: autoantibodies against G2s are closely associated with ophthalmopathy in patients with Graves' hyperthyroidism. Gunji K; De Bellis A; Li AW; Yamada M; Kubota S; Ackrell B; Wengrowicz S; Bellastella A; Bizzarro A; Sinisi A; Wall JR J Clin Endocrinol Metab; 2000 Apr; 85(4):1641-7. PubMed ID: 10770210 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]